1-7 of 7
Christopher J. Gibson
Close
Sort by
Journal Articles

Patient perspectives on testing for clonal hematopoiesis of indeterminate potential

Clinical Trials & Observations
Tal Sella, Geoffrey G. Fell, Peter G. Miller, Christopher J. Gibson, Shoshana M. Rosenberg, Craig Snow, Daniel G. Stover, Kathryn J. Ruddy, Jeffrey M. Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Elizabeth Frank, Donna S. Neuberg, Benjamin L. Ebert, Ann H. Partridge
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6151–6161.
https://doi.org/10.1182/bloodadvances.2022008376
Published: 2022
Includes: Supplemental data
Journal Articles

Allelic complexity of KMT2A partial tandem duplications in acute myeloid leukemia and myelodysplastic syndromes

Harrison K. Tsai, Christopher J. Gibson, H. Moses Murdock, Phani Davineni, Marian H. Harris, Eunice S. Wang, Lukasz P. Gondek, Annette S. Kim, Valentina Nardi, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4236–4240.
https://doi.org/10.1182/bloodadvances.2022007613
Published: 2022
Includes: Supplemental data
Journal Articles

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

Clinical Trials & Observations
Trine Alma Knudsen, Vibe Skov, Kristen Stevenson, Lillian Werner, William Duke, Charles Laurore, Christopher J. Gibson, Anwesha Nag, Aaron R. Thorner, Bruce Wollison, Dennis Lund Hansen, Christina Ellervik, Daniel El Fassi, Karin de Stricker, Lukas Frans Ocias, Mette Brabrand, Ole Weis Bjerrum, Ulrik Malthe Overgaard, Mikael Frederiksen, Thomas Kielsgaard Kristensen, Torben A. Kruse, Mads Thomassen, Torben Mourits-Andersen, Marianne Tang Severinsen, Jesper Stentoft, Joern Starklint, Donna S. Neuberg, Lasse Kjaer, Thomas Stauffer Larsen, Hans Carl Hasselbalch, R. Coleman Lindsley, Ann Mullally
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2107–2119.
https://doi.org/10.1182/bloodadvances.2021004856
Published: 2022
Includes: Supplemental data
Journal Articles

Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy

Peter G. Miller, Adam S. Sperling, Elliott J. Brea, Mark B. Leick, Geoffrey G. Fell, Max Jan, Satyen H. Gohil, Yu-Tzu Tai, Nikhil C. Munshi, Catherine J. Wu, Donna S. Neuberg, Marcela V. Maus, Caron Jacobson, Christopher J. Gibson, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2982–2986.
https://doi.org/10.1182/bloodadvances.2021004554
Published: 2021
Includes: Supplemental data
Journal Articles

Identification of germline variants in adults with hemophagocytic lymphohistiocytosis

Peter G. Miller, Abhishek Niroula, John J. Ceremsak, Christopher J. Gibson, Martin S. Taylor, Sebastian Birndt, Florian Perner, Jon Arnason, Adam S. Sperling, Mridul Agrawal, Alison M. Schram, Sarah Nikiforow, German Pihan, Robert P. Hasserjian, Jon C. Aster, Paul La Rosée, Elizabeth A. Morgan, Nancy Berliner, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2020) 4 (5): 925–929.
https://doi.org/10.1182/bloodadvances.2019001272
Published: 2020
Includes: Supplemental data
Journal Articles

Stem cell donors should not be screened for clonal hematopoiesis

Christopher J. Gibson, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2020) 4 (4): 789–792.
https://doi.org/10.1182/bloodadvances.2019000395
Published: 2020
Journal Articles

Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia

Elizabeth A. Morgan, Mark N. Lee, Daniel J. DeAngelo, David P. Steensma, Richard M. Stone, Frank C. Kuo, Jon C. Aster, Christopher J. Gibson, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1786–1789.
https://doi.org/10.1182/bloodadvances.2017011197
Published: 2017
Includes: Supplemental data